NEWS DESK

CMND Stock News, News Score & What It Could Mean

Clearmind Medicine Inc. - Common Shares (CMND) is currently showing a slightly bearish headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: There is a mild negative lean in the higher-value headlines, though the setup is not strong enough to call decisively bearish.
Change stock
Search another ticker to view its latest news page.
OPEN ON TRADINGVIEW ↗TRADE THIS STOCK
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
42/100
Slightly Bearish
Bearish
Neutral
Bullish
Earnings Tone
55
Unavailable based on actual EPS/revenue
Confidence
Low
Headline depth
Last Price
$2.15
Trend Context
Mixed / range
Latest briefing

What's happening with CMND

Quiver Quantitative19 May 2026

Clearmind Medicine Inc. Announces 1-for-10 Reverse Share Split to Regain Nasdaq Compliance | CMND Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNR2pyT2d6TmZmTC1ZN2tnb0IxSHVKeHZLdVlkZm01TERJaS1rM0lha25CQkJlcm1na093Q1VPSmZHaG9vMTFJTEFjdVlHb2pWcXA1R29SWnJtMDVPQnBoU3E1Zmx5Zm1tZ2RNWDh1eTJlYi12SDNYcG9DUXdUQ2FxaWlrZzZBWWNfU0xqZVU2X3pwcHM5Y2ZHMkcwT0NvdC1hY0ZRbXRkYXdHR0V5R3JPUGo5LWRuZDBPa1NlbUdCNjg?oc=5" target="_blank">Clearmind Medicine Inc. Announces 1-for-10 Reverse Share Split to Regain Nasdaq Compliance | CMND Stock News</a>&nbsp;&nbsp;<font color="#6f6f6f">Quiver Quantitative</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Earnings news

CMND earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
Quiver Quantitative13 Jul 2026

Clearmind Medicine Reports Positive Early Experience in Phase I/IIa Trial of Non-Hallucinogenic MEAI for Alcohol Use Disorder - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxQZW10T200Ym03TktsMTNCUDlfNk1tS1JkOG5LWnRaTExwRUlYTEVUOUNjTEZKaFlYSmJ0cDdaUmVsb1BuenJqZ0lOaVRvY1RaeXV2cVRRNHhyRE1PMFZ5bGYySmEyMlFYT2RhbklBM2xqQ3FzMTJkVnp2MlkzQWFQODVabnlZelpkdlQ0ajNCSHBNbTM2Sl9IaFpXUmw4Y00xUFlDaEN2OTRORmw1ano3X2FyU3NkZEtpREtyVGN6XzEteTdVYzEyWWxRUVRtVWxLbDd5ZkNtOUV4cW8tRVdGSnNueTN0dVVrVnBtQ3dSV2xoZw?oc=5" target="_blank">Clearmind Medicine Reports Positive Early Experience in Phase I/IIa Trial of Non-Hallucinogenic MEAI for Alcohol Use Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">Quiver Quantitative</font>

2
Quiver Quantitative10 Jul 2026

Clearmind Medicine Submits Response to HHS RFI Highlighting MEAI-Based CMND-100 for Alcohol Use Disorder - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxOTWZxTVg5TWE1ZDVHaUNlMF9icDB0T0Z3V1kyRUExZVlLUFJnQ0g5Z01DdHFvWmRyaEc4MDVCNGlBS2ZxcG1EN1hZLW04Ym84M0J1WGpzSlNYMnk4Zld4ejBQVTNPei1wMExwcjNDUUx4Q1BVdnFDcnVXV1FuSXBmaGJXaVdhNnQ2R3RFTjNzU2R2TnBaM25jcmF1MUFKbDJ1NEVoMjAwa3RWRHFYeFVJcThZdWRnNzgtV0tHS2M4X0dmODlXek9PNUlFQXN0OE1oY0Vn?oc=5" target="_blank">Clearmind Medicine Submits Response to HHS RFI Highlighting MEAI-Based CMND-100 for Alcohol Use Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">Quiver Quantitative</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your CMND research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.
Stock AnalysisOPEN ON TRADINGVIEW ↗TRADE THIS STOCK